MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    Variant frequencies in dystonia and Parkinson’s disease genes cross phenotypic boundaries

    L. Lange, A. Illarionova, K. Grütz, EJ. Vollstedt, B-H. Laabs, S. Löns, G. Kilic-Berkmen, F. Hinrichs, H. Padlock, L. Screven, T. Bäumer, H. Jinnah, N. Brüggemann, Z-H. Fang, K. Lohmann, C. Klein (Luebeck, Germany)

    Objective: To investigate the frequency of genetic variants in dystonia (DYT) genes in patients with PD and vice versa. Background: The impact of genetic variants…
  • 2023 International Congress

    Sex differences for off episodes in Parkinson’s disease

    A. Ratnavel, C. Jiang, A. Liu, K. Wang, A. Tsai, K. Wyman-Chick, E. Bayram (La Jolla, USA)

    Objective: To determine the sex differences for the frequency, duration, and impact of off episodes in Parkinson’s disease (PD). Background: Dopamine replacement therapy through oral…
  • 2023 International Congress

    Multi-stakeholder focus group study to develop recommendations of ways to improve treatment burden and capacity in Parkinson’s disease

    QY. Tan, S. Fraser, H. Roberts, K. Ibrahim (Southampton, United Kingdom)

    Objective: To develop recommendations of ways to improve treatment burden and capacity in Parkinson’s disease (PD) Background: Our research has identified potentially modifiable factors of…
  • 2023 International Congress

    Contribution of MRI and machine learning approaches to the diagnosis of patients with early-stage parkinsonism in a situation of clinical uncertainty

    L. Chougar, A. Faucher, J. Faouzi, FX. Lejeune, F. Cormier, M. Vidailhet, O. Colliot, S. Lehericy, D. Grabli, B. Degos (PARIS, France)

    Objective: To determine whether MRI and machine learning approaches improve diagnostic accuracy in patients with early-stage parkinsonism compared to clinical criteria Background: Parkinson’s disease (PD)…
  • 2023 International Congress

    Ethnic and Gender Disparities in Access to Deep Brain Stimulation for Parkinson’s Disease Among Participants in C-OPN

    I. Ojo, S. Poonja, J. Miyasaki, A. Shetty, T. Sankar, F. Ba (Edmonton, Canada)

    Objective: To study the disparities in gender and ethnicity and the related contributing factors in Parkinson’s disease (PD) patients who require deep brain stimulation (DBS),…
  • 2023 International Congress

    Effort-based decision-making and neuropsychiatric symptoms before and after subthalamic nucleus deep brain stimulation in Parkinson’s disease

    D. Amstutz, M. Sousa, K. Petermann, A. Botros, M. Maradan-Gachet, I. Debove, L. Lachenmayer, A. Diamantaras, J. Waskönig, C. Pollo, D. Cazzoli, T. Nef, M. Husain, P. Krack (Bern, Switzerland)

    Objective: Parkinson’s disease patients with apathy and patients in the medication OFF state show reduced reward sensitivity in effort-based decision-making tasks. The effect of subthalamic…
  • 2023 International Congress

    The impact of mild cognitive impairment on functioning in people with Parkinson’s disease

    J. Petrillo, TM. Brown, K. Paumier, J. Dine, R. Sawant, S. Baradaran, A. Koenig (Cambridge, USA)

    Objective: To understand the experience of mild cognitive impairment (MCI) in people with Parkinson’s disease (PwP) and its impact on daily life. Background: Parkinson’s disease…
  • 2023 International Congress

    Combination COMT inhibitor with Levodopa reduces consumption of vitamin B6

    D. Kamiyama, N. Nishikawa, S. Ueno, C. Abe, T. Hatano, N. Hattori (Tokyo, Japan)

    Objective: To investigate changes in Levodopa (LD) pharmacokinetics and changes in homocysteine, vitamin B6, and vitamin B12 in Parkinson's disease (PD) patients receiving LD formulations…
  • 2023 International Congress

    Is STN a good target for decrease off period by DBS, Gpi – for reduction of dyskinesia in PD patients?

    A. Buniak, V. Alexeyevets, S. Likhachev, V. Bayarchyk (Minsk, Belarus)

    Objective: To study the efficiency of DBS GPI in PD patients compared to DBS STN in Republican center of neurology and neurosurgery in Belarus Background:…
  • 2023 International Congress

    Determinants of quality of life and daily mobility in Parkinson’s disease: the role of fear of falling.

    A. Magliozzi, V. Pozzilli, G. Sergi, V. Di Lazzaro, M. Marano (Roma, Italy)

    Objective: We aimed to investigate the relationship between the PD clinical features, the presence of FOF and its impact on QoL. We explored whether the…
  • « Previous Page
  • 1
  • …
  • 118
  • 119
  • 120
  • 121
  • 122
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
      • Welcome to the MDS Abstracts Site
      • Effect of marijuana on Essential Tremor: A case report
      • Advanced Search
      • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
      • Covid vaccine induced parkinsonism and cognitive dysfunction
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley